Exact Sciences Statistics Share Statistics Exact Sciences has 189.32M
shares outstanding. The number of shares has increased by 2.09%
in one year.
Shares Outstanding 189.32M Shares Change (YoY) 2.09% Shares Change (QoQ) 1.55% Owned by Institutions (%) 97.42% Shares Floating 186.87M Failed to Deliver (FTD) Shares 11 FTD / Avg. Volume n/a
Short Selling Information The latest short interest is 7.47M, so 3.96% of the outstanding
shares have been sold short.
Short Interest 7.47M Short % of Shares Out 3.96% Short % of Float 4.53% Short Ratio (days to cover) 3.08
Valuation Ratios The PE ratio is -10.06 and the forward
PE ratio is 117.04.
Exact Sciences's PEG ratio is
-0.03.
PE Ratio -10.06 Forward PE 117.04 PS Ratio 3.75 Forward PS 2.2 PB Ratio 4.31 P/FCF Ratio 138.84 PEG Ratio -0.03
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for Exact Sciences.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 2.15,
with a Debt / Equity ratio of 1.15.
Current Ratio 2.15 Quick Ratio 1.92 Debt / Equity 1.15 Debt / EBITDA -3.49 Debt / FCF 36.95 Interest Coverage -32.8
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee $399.84K Profits Per Employee $-149.11K Employee Count 6,900 Asset Turnover 0.47 Inventory Turnover 5.17
Taxes Income Tax -7.3M Effective Tax Rate 0.7%
Stock Price Statistics The stock price has increased by -28.85% in the
last 52 weeks. The beta is 0.93, so Exact Sciences's
price volatility has been higher than the market average.
Beta 0.93 52-Week Price Change -28.85% 50-Day Moving Average 51.74 200-Day Moving Average 53 Relative Strength Index (RSI) 24.55 Average Volume (20 Days) 3,118,320
Income Statement In the last 12 months, Exact Sciences had revenue of 2.76B
and earned -1.03B
in profits. Earnings per share was -5.59.
Revenue 2.76B Gross Profit 1.92B Operating Income -1.05B Net Income -1.03B EBITDA -788.73M EBIT -1B Earnings Per Share (EPS) -5.59
Full Income Statement Balance Sheet The company has 600.89M in cash and 2.75B in
debt, giving a net cash position of -2.15B.
Cash & Cash Equivalents 600.89M Total Debt 2.75B Net Cash -2.15B Retained Earnings -4.5B Total Assets 5.8B Working Capital 985.93M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was 210.54M
and capital expenditures -135.99M, giving a free cash flow of 74.55M.
Operating Cash Flow 210.54M Capital Expenditures -135.99M Free Cash Flow 74.55M FCF Per Share 0.4
Full Cash Flow Statement Margins Gross margin is 69.55%, with operating and profit margins of -38.01% and -37.29%.
Gross Margin 69.55% Operating Margin -38.01% Pretax Margin -37.56% Profit Margin -37.29% EBITDA Margin -28.59% EBIT Margin -38.01% FCF Margin 2.7%
